Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126386551 | 12638655 | 1 | I | 20160729 | 20160809 | 20160809 | EXP | US-TEVA-683672USA | TEVA | BIEBER AK, COHEN DE, STEIN JA. SYSTEMIC METHOTREXATE FOR PRURIGO NODULARIS AND KERATOACANTHOMAS IN ACTINICALLY DAMAGED SKIN. JAAD CASE REPORTS. 2016; 2(3): 269-271 | 80.00 | YR | F | Y | 0.00000 | 20160809 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126386551 | 12638655 | 1 | PS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | Y | 65078 | ||||||||||
| 126386551 | 12638655 | 2 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Y | 65078 | |||||||||||
| 126386551 | 12638655 | 3 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Y | 65078 | |||||||||||
| 126386551 | 12638655 | 4 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Y | 65078 | |||||||||||
| 126386551 | 12638655 | 5 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | Y | 65457 | ||||||||||
| 126386551 | 12638655 | 6 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Y | 65457 | |||||||||||
| 126386551 | 12638655 | 7 | C | ACITRETIN. | ACITRETIN | 1 | Y | 0 | |||||||||||
| 126386551 | 12638655 | 8 | C | ACITRETIN. | ACITRETIN | 1 | Y | 0 | |||||||||||
| 126386551 | 12638655 | 9 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | 0 | ||||||||||||
| 126386551 | 12638655 | 10 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | 0 | ||||||||||||
| 126386551 | 12638655 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 126386551 | 12638655 | 12 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126386551 | 12638655 | 1 | Eczema |
| 126386551 | 12638655 | 2 | Neurodermatitis |
| 126386551 | 12638655 | 3 | Neurodermatitis |
| 126386551 | 12638655 | 4 | Eczema |
| 126386551 | 12638655 | 5 | Eczema |
| 126386551 | 12638655 | 6 | Neurodermatitis |
| 126386551 | 12638655 | 7 | Neurodermatitis |
| 126386551 | 12638655 | 8 | Eczema |
| 126386551 | 12638655 | 9 | Neurodermatitis |
| 126386551 | 12638655 | 10 | Eczema |
| 126386551 | 12638655 | 11 | Neurodermatitis |
| 126386551 | 12638655 | 12 | Eczema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126386551 | 12638655 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126386551 | 12638655 | Condition aggravated | |
| 126386551 | 12638655 | Keratoacanthoma | |
| 126386551 | 12638655 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |